1. Home
  2. BY vs FTRE Comparison

BY vs FTRE Comparison

Compare BY & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BY

Byline Bancorp Inc.

HOLD

Current Price

$32.51

Market Cap

1.5B

Sector

Finance

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$10.70

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BY
FTRE
Founded
1914
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
2017
2023

Fundamental Metrics

Financial Performance
Metric
BY
FTRE
Price
$32.51
$10.70
Analyst Decision
Buy
Buy
Analyst Count
2
10
Target Price
$33.50
$15.50
AVG Volume (30 Days)
157.7K
1.8M
Earning Date
04-22-2026
05-25-2026
Dividend Yield
1.51%
N/A
EPS Growth
3.00
N/A
EPS
2.12
N/A
Revenue
N/A
$2,696,400,000.00
Revenue This Year
$17.06
$3.21
Revenue Next Year
$2.84
$0.25
P/E Ratio
$15.27
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.63
$3.97
52 Week High
$33.89
$18.67

Technical Indicators

Market Signals
Indicator
BY
FTRE
Relative Strength Index (RSI) 54.16 34.60
Support Level $32.00 $9.35
Resistance Level $33.89 $11.46
Average True Range (ATR) 0.83 1.19
MACD -0.18 -0.11
Stochastic Oscillator 43.46 29.16

Price Performance

Historical Comparison
BY
FTRE

About BY Byline Bancorp Inc.

Byline Bancorp Inc is the holding company for Byline Bank, a full-service commercial bank serving small-and-medium sized businesses, financial sponsors, and consumers. The company offers a broad range of banking products and services to small and medium sized businesses, commercial real estate and online account opening to consumer and business. Also provide trust and wealth management services to its customers. In addition to traditional commercial banking business, company provide small ticket equipment leasing solutions through Byline Financial Group, a wholly-owned subsidiary of Byline Bank.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: